| 272 | 0 | 121 |
| 下载次数 | 被引频次 | 阅读次数 |
清代叶桂提出“久病入络”的络病发病规律。根据病毒性呼吸系统疾病的病程久暂为相对概念，通过系统梳理历代文献，发现“新感”属“新病”范畴，指出“新病”包括邪气初入正气未伤、旧病未除新病复起和痼疾猝发等类型，并不拘于外感疾病；“新感”指感受温热邪气、六淫和疫疠之气等所致的疾病，不同于现代中医药学名词术语中相对于“伏邪温病”而言的新感温病。基于《黄帝内经》“络-经-络”传变途径、《伤寒论》所述外邪由经络传至脏腑的发病规律，以及叶桂从“络”角度阐释的外感温热病传变规律，提出“新感入络”的概念，并进一步分析认为，“新感入络”符合病毒类呼吸系统疾病传变规律及病机特点，制定“清瘟解毒、宣肺泄热”治法，对病毒性呼吸系统传染病防控具有重要作用。
Abstract：In the Qing Dynasty, YE Gui proposed the pathogenesis of "chronic diseases entering the collaterals"as a rule for collateral diseases. In the context of viral respiratory diseases, the course of the disease is considered a relative concept. A systematic review of historical literature reveals that "new pathogens" belong to the category of "new diseases". It identifies that "new diseases" include types where the pathogenic qi initially invades without harming the righteous qi, where old diseases relapse while not being completely cured, and where chronic diseases suddenly flare up. These are not limited to exogenous diseases. "New pathogens" refer to diseases caused by the invasion of warm-heat pathogens, the six excesses, and epidemic qi, differing from the modern traditional Chinese medicine term "new warm diseases" related to latent heat diseases. Based on the "collaterals-meridians-collaterals" transformation pathway described in The Inner Canon of Yellow Emperor （《黄帝内经》） and the pathogenesis of external pathogens entering the zang-fu organs via the meridians as described in Treatise on Febrile Disease （《伤寒论》）, as well as the external warm diseases' transformation rule explained by YE Gui from the perspective of collaterals, the concept of "new pathogen invading the collaterals" is proposed. Further analysis indicates that this concept aligns with the transmission and pathogenesis patterns of viral respiratory diseases. The treatment method of "clearing epidemic pathogens, detoxifying, and spreading the lung to relieve heat" is considered important for the prevention and control of viral respiratory infectious diseases.
[1]蔡永敏，唐学敏，李琳珂，等.中医名词考证与规范（第一卷：总论、中医基础理论）[M].上海：上海科技文献出版社，2021:630-633.
[2]BARROS-ARAGAO FGQ, PINTO TP, CARREGARI VC, et al. Changes in neuroinflammatory biomarkers correlate with disease severity and neuroimaging alterations in patients with COVID-19 neurological complications[J].Brain Behav Immun Health, 2024, 39:100805. doi:org/10. 1016/j. bbih. 2024. 100805.
[3]AVORIO F, RUSSELLI G, PANARELLO G, et al. Neurological complications of SARS-CoV-2 infection among solid organ transplanted patients:does immunosuppression matter?[J]. Front Neurol, 2024, 15:1393104.doi:10. 3389/fneur. 2024. 1393104.
[4]AGA M, OKUBO S, IKEDA T, et al. Multiple lung abscesses and cold agglutinin syndrome following coronavirus disease 2019:a case report[J]. J Med Case Rep,2024, 18(1):318.
[5]FRAMPTON J, ORTENGREN AR, ZEITLER EP. Arrhythmias after acute myocardial infarction[J]. Yale J Biol Med, 2023, 96(1):83-94.
[6]JENCA D, MELENOVSKY V, STEHLIK J, et al. Heart failure after myocardial infarction:incidence and predictors[J]. ESC Heart Failure, 2020, 8(1):222-237.
[7]CHEN J, WANG X, YE W. Prognostic analysis of sex and age in hepatocellular carcinoma:a SEER study[J].Eur J Gastroenterol Hepatol, 2024, 36(5):646-651.
[8]GOKTAS AS, BILICI A, CALIS E, et al. Impact of SPARC expression on treatment response of pembrolizumab and brain metastasis in patients with metastatic non-small cell lung cancer[J]. Int Immunopharmacol, 2023, 124(Pt B):110947.
[9]LIU B, TANG L, PENG N, et al. Lung and bone metastases patterns in limb osteosarcoma:surgical treatment of primary site improves overall survival[J]. Medicine, 2023, 102(42):e35671.
[10]GROTE I, POPPE A, LEHMANN U, et al. Frequency of genetic alterations differs in advanced breast cancer between metastatic sites[J]. Gene Chromosome Canc,2023, 63(1):e23199.
[11]肖啸，张琦.张仲景诸“家”代表的痼疾观对慢性复杂性疾病辨治启示[J].中华中医药杂志，2020, 35(5):2248-2253.
[12]TOOLE KP, FRANK C. A near miss in the emergency department[J]. Adv Emerg Nurs J, 2024, 46(2):108-117.
[13]CHEN H, ZHANG L, LI Y, et al. Gut microbiota and its metabolites:the emerging bridge between coronary artery disease and anxiety and depression?[J/OL].Aging Dis.(2024-07-02)[2025-02-26]. https：//pubmed.ncbi. nlm. nih. gov/39012662/.
[14]VASSE GF, MELGERT BN. Microplastic and plastic pollution:impact on respiratory disease and health[J].Eur Respir Rev, 2024, 33(172):230226.
[15]OTOSHI R, IKEDA S, KANEKO T, et al. Treatment strategies for non-small-cell lung cancer with comorbid respiratory disease; interstitial pneumonia, chronic obstructive pulmonary disease, and tuberculosis[J]. Cancers,2024, 16(9):1734.
[16]FUNG NH, NGUYEN QA, OWCZAREK C, et al. Earlylife house dust mite aeroallergen exposure augments cigarette smoke-induced myeloid inflammation and emphysema in mice[J]. Respir Res, 2024, 25(1):161.
[17]袁钟，图娅，彭泽邦，等.中医辞海：下册[M].北京：中国医药科技出版社，1999:353.
[18]李振吉.中医药常用名词术语辞典[M].北京：中国中医药出版社，2001:416.
[19]中医药学名词审定委员会.中医药学名词[M].北京：科学出版社，2005:42.
[20]赵明芬，安冬青，汪建萍.试论伏邪理论的源流及发展[J].中医杂志，2016, 57(3):189-192.
[21]世界卫生组织（西太平洋地区）. WHO西太平洋地区传统医学名词术语国际标准[M].北京大学第一医院中西医结合研究所，译.北京：北京大学医学出版社，2009:157.
[22]马宇博，贾婷婷.浅谈中医疫病病因理论[J].光明中医，2024, 39(8):1668-1672.
[23]贾振华.肺疫证治规律探讨与连花清瘟组方新解[J].中国实验方剂学杂志，2024, 30(17):203-210.
[24]王宣，李霞.从络病理论探讨肺间质纤维化的微循环改变[J].中医杂志，2018, 59(9):743-745.
[25]袁国强，吴以岭，魏聪，等脉络病变基本病机探析[J].中医杂志，2012, 53(13):1088-1091.
[26]吴以岭.络病理论体系构建及其学科价值[J].前沿科学，2007(2):40-46.
[27]王喜红，韩振蕴，许梦白，等.新型冠状病毒致病的中医认识和思考[J].北京中医药大学学报，2020, 43(7):539-543.
[28]齐浩翔，柴鑫华，鲍永霞.新冠病毒肺炎后肺纤维化的研究进展[J].临床肺科杂志，2024, 29(8):1275-1280.
[29]李红蓉，吴以岭.络病研究的传承与创新[J].南京中医药大学学报，2022, 38(12):1075-1085.
[30]贾振华，魏聪，李红蓉，等肺络病变证治研究[J].南京中医药大学学报，2019, 35(5):484-490.
[31]尹玉洁，常丽萍.中药连花清瘟胶囊/颗粒在呼吸系统疾病中的药理研究及临床应用进展[J].中国临床药理学与治疗学，2021, 26(10):1174-1180.
基本信息:
DOI：10.13288/j.11-2166/r.2025.08.003
中图分类号:R228
引用信息:
[1]贾振华.“新感入络”概念的提出及其临床应用价值[J].中医杂志,2025,66(08):775-779.DOI:10.13288/j.11-2166/r.2025.08.003.
基金信息:
国家自然科学基金（82130123）; 国家中医药管理局中医药创新团队及人才支持计划（ZYYCXTD-D-202206）; 河北省省级科技计划（24462501D）